Company Profile
Shenzhen Neptunus Bioengineering develops, produces, and sells Chinese patent medicines, infusion products, and western medicine preparations in China. The company provides oryzanol tablets, chlorpheniramine maleate tablets, estazolam tablets, and rifampicin capsules
Technical support for generic drug quality consistency evaluation and medical R&D work. It also distributes drugs, medical devices, and medical supplies; and offers value-added services for hospitals, medical institutions, and drug retail institutions and distributors
Drugs in the fields of malignant tumors, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, diabetes, infectious diseases, and multiple diseases, such as respiratory system and digestive system.
It develops HW130 injection that completed the Phase I clinical trial for anti-tumor; and NEP018 for anti-tumor. Founded in 1992, Shenzhen Neptunus Bioengineering is headquartered in Shenzhen, China.